Refining letermovir prophylaxis strategies and CD4 + T cell-guided discontinuation in aplastic anemia patients post-allogeneic HSCT: a retrospective analysis.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41555441

Caixia Wang; Fangfang Yang; Liangliang Wu; Ming Zhou; Qi Xiang; Ruiqing Zhou; Shilin Xu; Shiyi Pan; Shunqing Wang; Tingfen Deng; Wei Zhou; Wenjian Mo; Xiaoqing He; Xiaowei Chen; Yuling Zhang; Yumiao Li; Yuping Zhang

Jan 20, 2026